EarningsQ2 2025 Earnings Report

Recursion Pharmaceuticals (RXRX) Q2 2025 Earnings Report

7 Followers

MX:RXRX Q2 2025 EPS Results

Actual EPS-$6.97

Consensus EPS-$6.00

Beat/MissMissed by -$0.97

One Year Ago EPS-$6.80

Actual Revenue$326.94M

Expected Revenue$261.36M

Beat/MissBeat by +$65.58M

YoY Revenue Growth+33.34%

QuarterQ2 2025

Date08/05/2025

TimeBefore Open

Conference CallTuesday, August 5, 2025

MX:RXRX Upcoming Earnings

Recursion Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:RXRX Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-3.72 / -	-6.123	―
Aug 05, 2026	2026 (Q2)	-4.08 / -4.25	-6.973	39.02% (+2.72)
May 06, 2026	2026 (Q1)	-4.51 / -3.74	-8.504	56.00% (+4.76)
Feb 25, 2026	2025 (Q4)	-5.12 / -3.57	-9.014	60.38% (+5.44)
Nov 05, 2025	2025 (Q3)	-6.41 / -6.12	-5.783	-5.88% (-0.34)
Aug 05, 2025	2025 (Q2)	-6.00 / -6.97	-6.803	-2.50% (-0.17)
May 05, 2025	2025 (Q1)	-8.78 / -8.50	-6.633	-28.21% (-1.87)
Feb 28, 2025	2024 (Q4)	-6.99 / -9.01	-7.143	-26.19% (-1.87)
Nov 06, 2024	2024 (Q3)	-5.66 / -5.78	-7.313	20.93% (+1.53)
Aug 08, 2024	2024 (Q2)	-6.53 / -6.80	-6.463	-5.26% (-0.34)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed